Assessing Patients for Treatment with ER/LA Opioid Analgesics
This program is developed through a providership between the University of North Texas Health Science Center and Antidote Education Company.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.
Release date: February 27, 2015
Valid through: February 27, 2016
Specialty: Primary Care
Estimated Time to Complete: 60 minutes
This activity is intended to educate primary care and specialist providers who treat patients with chronic pain.
This session is the first in a four part series on managing chronic pain with extended release and long-acting opioids.
Beginning with a brief commentary on the state of opioids in the US, Drs. Charles Argoff and Louis Kuritzky look at assessing patients for treatment with ER/LA opioids. Discussion will include patient evaluation, the risk associated with these opioid medications, key definitions of terms used in opioid treatment and a look at risk factors for opioid-related aberrant behaviors.
Upon completion of this activity, participants should be better able to:
- Describe how to assess patients for treatment with ER/LA opioid analgesics.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ , 1.0 AOA Category 2B CME Credits, and/or 1.0 AAFP Prescribed Credit.
- Nurse Practitioners — AANP Credit
- Physician Assistants — AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.
All other healthcare professionals completing this course will be issued a statement of participation.
Dr. Argoff is Professor of Neurology at Albany Medical College and Director of the Comprehensive Pain Center at Albany Medical Center in New York. Dr. Argoff is a member of the American Academy of Neurology, the International Association for the Study of Pain, the American Academy of Pain Medicine, and the American Pain Society, among other professional organizations. He is the President of the American Academy of Pain Medicine Foundation Board. Dr. Argoff is one of the editors of the recently published texbook, Raj's Practical Management of Pain, Fifth Edition. He is the co-author of Defeat Chronic Pain Now, a just published book for people with chronic pain. He has recently published the third edition of Pain Management Secrets.
Dr. Kuritzky is a family physician and clinical assistant professor at the Department of Community Health and Family Medicine at University of Florida in Gainesville. He received his medical degree from the Medical College of Virginia in Richmond and completed his internship at Miami Valley Hospital in Dayton, Ohio.
Prior to joining the faculty at the University of Florida in 1983, Dr. Kuritzky was a member of the UCLA Family Medicine Clinical Faculty. His professional society participation includes the American Society of Hypertension (ASH), the American Diabetes Association (ADA), and the American Association of Family Physicians (AAFP), among others. In addition to being board-certified in family medicine by the American Board of Family Medicine, he has received certification as a specialist in hypertension by the ASH.Dr. Kuritzky has given hundreds of presentations nationally and internationally at professional societies. He has authored over 100 articles in journals including the New England Journal of Medicine, Journal of the American Medical Association, Comprehensive Therapy, Hospital Practice, and Patient Care.
The University of North Texas Health Science Center at Fort Worth is accredited by the American Osteopathic Association to award continuing medical education to physicians.
The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 4 hours of AOA Category 2B CME credits. Approval is currently pending.
The University of North Texas Health Science Center at Fort Worth designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This Enduring Material activity, Effective Strategies for Chronic Pain Management: Assessing Patients for Treatment has been reviewed and is acceptable for up to 4.0 Prescribed credits by the American Academy of Family Physicians. Term of approval begins 2/27/2015. Term of approval is for one year from this date. Each webcast is approved for 1.0 Prescribed credit. Credit may be claimed for one year from the date of each webcast. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 4.0 contact hour(s) of continuing education (which includes 2.28 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 1411483. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Disclosures of Conflicts of Interest
The University of North Texas Health Science Center (UNTHSC) and Antidote Education Company (Antidote) are committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME's policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our activities are planned and implemented free of the control of commercial interests and to identifying and resolving conflicts of interest of all persons in a position to control the content of an educational activity before the educational activity occurs.
Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with commercial interests:
Charles Argoff, MD
Research: Endo Pharmaceuticals
Consultant: Pfizer, Teva Pharmaceutical Industries, Ltd., Daiichi Sankyo, Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Purdue, Zogenix Inc., Nektar Therapeutics
Speaker: Janssen Pharmaceuticals, Inc.
Louis Kuritzky, MD
Nothing to disclose
All UNTHSC and Antidote staff members and others involved in the planning, development and review of the content of this activity have no relevant conflicts of interest to disclose.
Instructions for Participation and Credit
This activity is comprised of 4 sessions. Each session will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online video and complete the post-test and evaluation form. To receive credit, a minimum score of 70% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of a certificate.
Internet streaming video
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.
Disclosure of Unlabeled Use
This activity does not include intentional, prescribed unlabeled use of pharmaceuticals. There is discussion of the consequences of drug misuse.
The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
This educational program and its content are copyright 2014-2015 by Antidote Education Company and the University of North Texas Health Science Center.